305 related articles for article (PubMed ID: 33904801)
1. Randomized, placebo-controlled, 28-day safety and pharmacokinetics evaluation of repeated oral cannabidiol administration in healthy dogs.
Vaughn DM; Paulionis LJ; Kulpa JE
Am J Vet Res; 2021 May; 82(5):405-416. PubMed ID: 33904801
[TBL] [Abstract][Full Text] [Related]
2. A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects.
Taylor L; Gidal B; Blakey G; Tayo B; Morrison G
CNS Drugs; 2018 Nov; 32(11):1053-1067. PubMed ID: 30374683
[TBL] [Abstract][Full Text] [Related]
3. Don't Fear the Reefer-Evidence Mounts for Plant-Based Cannabidiol as Treatment for Epilepsy.
Perry MS
Epilepsy Curr; 2019; 19(2):93-95. PubMed ID: 30955420
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and Safety Evaluation of Various Oral Doses of a Novel 1:20 THC:CBD
Chicoine A; Illing K; Vuong S; Pinto KR; Alcorn J; Cosford K
Front Vet Sci; 2020; 7():583404. PubMed ID: 33134364
[No Abstract] [Full Text] [Related]
5. Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial.
Schoedel KA; Szeto I; Setnik B; Sellers EM; Levy-Cooperman N; Mills C; Etges T; Sommerville K
Epilepsy Behav; 2018 Nov; 88():162-171. PubMed ID: 30286443
[TBL] [Abstract][Full Text] [Related]
6. Preliminary Investigation of the Safety of Escalating Cannabinoid Doses in Healthy Dogs.
Vaughn D; Kulpa J; Paulionis L
Front Vet Sci; 2020; 7():51. PubMed ID: 32118071
[No Abstract] [Full Text] [Related]
7. Pharmacokinetics of Cannabidiol in Sprague-Dawley Rats After Oral and Pulmonary Administration.
Schwotzer D; Kulpa J; Trexler K; Dye W; Jantzi J; Irshad H; Ware MA; Bonn-Miller M; McDonald J; Lefever T
Cannabis Cannabinoid Res; 2023 Apr; 8(2):360-373. PubMed ID: 36301522
[No Abstract] [Full Text] [Related]
8. Cannabidiol plasma determination and pharmacokinetics conducted at beginning, middle and end of long-term supplementation of a broad-spectrum hemp oil to healthy adult dogs.
Corsato Alvarenga I; Gustafson D; Banks K; Wilson K; McGrath S
Front Vet Sci; 2023; 10():1279926. PubMed ID: 37841465
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics, Safety, and Synovial Fluid Concentrations of Single- and Multiple-Dose Oral Administration of 1 and 3 mg/kg Cannabidiol in Horses.
Yocom AF; O'Fallon ES; Gustafson DL; Contino EK
J Equine Vet Sci; 2022 Jun; 113():103933. PubMed ID: 35307550
[TBL] [Abstract][Full Text] [Related]
10. Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome.
Devinsky O; Patel AD; Thiele EA; Wong MH; Appleton R; Harden CL; Greenwood S; Morrison G; Sommerville K;
Neurology; 2018 Apr; 90(14):e1204-e1211. PubMed ID: 29540584
[TBL] [Abstract][Full Text] [Related]
11. A phase 1, randomized, pharmacokinetic trial of the effect of different meal compositions, whole milk, and alcohol on cannabidiol exposure and safety in healthy subjects.
Crockett J; Critchley D; Tayo B; Berwaerts J; Morrison G
Epilepsia; 2020 Feb; 61(2):267-277. PubMed ID: 32012251
[TBL] [Abstract][Full Text] [Related]
12. Randomized blinded controlled clinical trial to assess the effect of oral cannabidiol administration in addition to conventional antiepileptic treatment on seizure frequency in dogs with intractable idiopathic epilepsy.
McGrath S; Bartner LR; Rao S; Packer RA; Gustafson DL
J Am Vet Med Assoc; 2019 Jun; 254(11):1301-1308. PubMed ID: 31067185
[TBL] [Abstract][Full Text] [Related]
13. Sex Differences in the Pharmacokinetics of Cannabidiol and Metabolites Following Oral Administration of a Cannabidiol-Dominant Cannabis Oil in Healthy Adults.
MacNair L; Kulpa J; Hill ML; Eglit GML; Mosesova I; Bonn-Miller MO; Peters EN
Cannabis Cannabinoid Res; 2023 Jun; ():. PubMed ID: 37267269
[No Abstract] [Full Text] [Related]
14. A pilot safety, tolerability and pharmacokinetic study of an oro-buccal administered cannabidiol-dominant anti-inflammatory formulation in healthy individuals: a randomized placebo-controlled single-blinded study.
Vitetta L; Butcher B; Henson JD; Rutolo D; Hall S
Inflammopharmacology; 2021 Oct; 29(5):1361-1370. PubMed ID: 34357480
[TBL] [Abstract][Full Text] [Related]
15. Tolerability of long-term cannabidiol supplementation to healthy adult dogs.
Corsato Alvarenga I; Wilson KM; McGrath S
J Vet Intern Med; 2024; 38(1):326-335. PubMed ID: 38009749
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics, Safety, and Clinical Efficacy of Cannabidiol Treatment in Osteoarthritic Dogs.
Gamble LJ; Boesch JM; Frye CW; Schwark WS; Mann S; Wolfe L; Brown H; Berthelsen ES; Wakshlag JJ
Front Vet Sci; 2018; 5():165. PubMed ID: 30083539
[No Abstract] [Full Text] [Related]
17. Long-term daily feeding of cannabidiol is well-tolerated by healthy dogs.
Bradley S; Young S; Bakke AM; Holcombe L; Waller D; Hunt A; Pinfold K; Watson P; Logan DW
Front Vet Sci; 2022; 9():977457. PubMed ID: 36213402
[TBL] [Abstract][Full Text] [Related]
18. Randomized, double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of Delta9-tetrahydrocannabinol (THC) after oral application of THC verses standardized cannabis extract.
Nadulski T; Pragst F; Weinberg G; Roser P; Schnelle M; Fronk EM; Stadelmann AM
Ther Drug Monit; 2005 Dec; 27(6):799-810. PubMed ID: 16306858
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of cannabidiol administered by 3 delivery methods at 2 different dosages to healthy dogs.
Bartner LR; McGrath S; Rao S; Hyatt LK; Wittenburg LA
Can J Vet Res; 2018 Jul; 82(3):178-183. PubMed ID: 30026641
[TBL] [Abstract][Full Text] [Related]
20. Drug-drug interaction between cannabidiol and phenobarbital in healthy dogs.
Doran CE; McGrath S; Bartner LR; Thomas B; Cribb AE; Gustafson DL
Am J Vet Res; 2021 Nov; 83(1):86-94. PubMed ID: 34727050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
